IIPR

2nd Quarter 2026 4-S Report

I. Snapshot My Implied Share Price: $34.43 My Current Holdings Symbol Price Weight Cash 1.00 25.12% PETS 1.98 12.59% AII 19.27 8.11% IIPR 63.36 2.84% WEYS 39.49 2.83% ZM 87.15 2.57% PINS 22.07 2.07% MED 10.96 2.07% UPWK 9.16 1.99% EXE 90.72 1.95% USNA 21.51 1.91% BBBY 5.83 1.85% FVRR 10.81 1.84% MKL 1979.65 1.77% […]

2nd Quarter 2026 4-S Report Read More »

Updates, Holdings, Allocation, Rebalancing, and 4-S Report Related

June 25, 2026 Owner’s Decisions – Snapshot, Situation, Response, and Reflections (Re: BBBY, LULU, ACN, UPWK, FVRR, PETS, WEYS, USNA, MED, SITC, IIPR, and EXE)

Snapshot My Implied Share Price: $32.62 Situation I wanted to fund additional opportunities in LULU and ACN, and rebalance my portfolio. Response I took some profits in BBBY, still leaving a good amount of exposure. I am excited about UPWK because it is similar to FVRR.  I also found it to be undervalued.  After I

June 25, 2026 Owner’s Decisions – Snapshot, Situation, Response, and Reflections (Re: BBBY, LULU, ACN, UPWK, FVRR, PETS, WEYS, USNA, MED, SITC, IIPR, and EXE) Read More »

Decisions: Owner's Snapshot, Situation, Response, and Reflections (SSRRs)

October 2025 – 3-S Report

PART I. Snapshot My Implied Share Price: $31.15 My Current Holdings Symbol Price Weight CASH 1.00 30.97% MOV 19.59 8.27% PETS 2.62 6.31% Options 1.00 4.54% AII 22.73 4.42% IIPR 56.46 3.91% TGT 89.03 3.38% INTC 36.83 3.11% MED 13.99 3.10% CROX 84.89 2.65% UG 7.755 2.42% CNC 38.70 1.96% LNC 41.09 1.94% VZ 43.67

October 2025 – 3-S Report Read More »

Updates, Holdings, Allocation, Rebalancing, and 4-S Report Related
Close-up of professionals reviewing financial graphs at a business meeting.

February 10, 2025 Decisions – Quick Note: Reviewing This Past Week (Re: IIPR, PZZA, CROX, BGS, WBA, AISP, ADM, and REYN)

Over the last month, I believe I’ve made some good subsidiary acquisitions. IIPR First, I added more Innovative Industrial Properties, Inc. (IIPR).  I look at this more from the real estate and assets perspective rather than just as a medical marijuana industry company investment.  The company only had about $450M in debt on its balance

February 10, 2025 Decisions – Quick Note: Reviewing This Past Week (Re: IIPR, PZZA, CROX, BGS, WBA, AISP, ADM, and REYN) Read More »

Decisions: Owner's Snapshot, Situation, Response, and Reflections (SSRRs)